Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
05/2012
05/10/2012US20120116051 Polymer Conjugate Of Bioactive Substance Having Hydroxy Group
05/10/2012US20120115958 Liquid pharmaceutical formulation containing paracetamol
05/10/2012US20120115957 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
05/10/2012US20120115947 Combination/association of adapalene and benzoyl peroxide for treating acne lesions
05/10/2012US20120115940 Use of total coumarins of cnidium fruit in preparing medicaments for treating psoriasis
05/10/2012US20120115923 Sirna Compositions Promoting Scar-Free Wound Healing of Skin and Methods for Wound Treatment
05/10/2012US20120115916 Oxazole and thiazole derivatives as alx receptor agonists
05/10/2012US20120115905 Nitrone, Nitroso, and Nitroxide Spintraps and Spin Labels and Their Hydroxylamines
05/10/2012US20120115903 Substituted Heteroaromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
05/10/2012US20120115902 3H-Imidazo [4, 5-B] Pyridine- 6 -Carboxamides As Anti-Inflammatory Agents
05/10/2012US20120115897 Aryl (Ethanoic) Propanoic Acid Ascorbyl Ester, Preparation Method Thereof And Medicament Containing The Same
05/10/2012US20120115895 Tricyclic indole-derived spiro derivatives as crth2 modulators
05/10/2012US20120115894 Imidazole derivatives useful as modulators of faah and as faah imaging agents
05/10/2012US20120115893 Substituted Bicyclic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
05/10/2012US20120115890 Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith
05/10/2012US20120115886 Fused pyrimidineone compounds as trpv3 modulators
05/10/2012US20120115874 Pyrazine derivatives, process for manufacture and use thereof
05/10/2012US20120115869 Tetrazole derivatives
05/10/2012US20120115865 New Salts of an Indole Derivative and Their Use in Medicine
05/10/2012US20120115864 Substituted Fused Pyrimidine Compounds
05/10/2012US20120115862 Dibenzocycloheptatone derivatives and pharmaceutical agents containing said compounds
05/10/2012US20120115861 Aminopyridine derivatives for treating tumors and inflammatory diseases
05/10/2012US20120115846 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof.
05/10/2012US20120115841 Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
05/10/2012US20120115840 Hemifumarate salt of 1-[4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl]-azetidine-3-carboxylic acid
05/10/2012US20120115832 TGR5 Modulators and Methods of Use Thereof
05/10/2012US20120115828 Medicinal cream containing miconazole nitrate, hydrocortisone acetate, and a biopolymer, and a process to make it
05/10/2012US20120115827 3-aminobenzamide compounds and vanilloid receptor subtype 1 (vr1) inhibitors
05/10/2012US20120115826 Derivatives of 4-(2-Amino-1-Hydroxyethyl) Phenol as Agonists of the Beta2 AdrenergicReceptor
05/10/2012US20120115825 Cyclohexyloxy-substituted heterocyclics, medicines containing these compounds and method for the production thereof
05/10/2012US20120115823 Bismuth-containing compounds, coordination polymers, methods for modulating pharmacokinetic properties of biologically active agents, and methods for treating patients
05/10/2012US20120115817 Phthalimide derivatives of non-steroidal anti-inflammatory compounds and/or tnf-alpha modulators, method for producing same, pharmaceutical compositions containing same and uses thereof for the treatment of inflammatory diseases
05/10/2012US20120115811 Phenylanaline amide derivatives useful for treating insulin-related diseases and conditions
05/10/2012US20120115808 Pharmacological preparation for topical use containing n-palmitoyl-vanillamide
05/10/2012US20120115797 Peptide compositions that downregulate tlr-4 signaling pathway and methods of producing and using same
05/10/2012US20120115789 Methylglyoxal-Scavenging Compounds and Their Use for the Prevention and Treatment of Pain and/or Hyperalgesia
05/10/2012US20120115782 Compositions and methods for treating or inhibiting liver injury
05/10/2012US20120115773 Modified omci as a complement inhibitor
05/10/2012US20120115772 Conjugation method
05/10/2012US20120114774 Methods and compositions for treating and preventing laminitis, founder and overeating in an ungulate
05/10/2012US20120114756 Sustained-release drug carrier composition
05/10/2012US20120114754 Rapidly disintegrating solid oral dosage form
05/10/2012US20120114749 Compositions and methods for delivery of embolics
05/10/2012US20120114745 Method for treating or ameliorating mucocutaneous or ocular toxicities
05/10/2012US20120114743 Transdermal ricinoleic acid compositions
05/10/2012US20120114740 Sustained release formulation of a non-steroidal anti-inflammatory drug
05/10/2012US20120114739 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
05/10/2012US20120114737 Silicone acrylate hybrid composition and method of making same
05/10/2012US20120114716 Flowable Carrier Matrix
05/10/2012US20120114715 Use of larch wood for treating inflammation
05/10/2012US20120114706 Endorphin Therapy Compositions and Methods of Use Thereof
05/10/2012US20120114705 Water soluble film for oral administration with instant wettability
05/10/2012US20120114703 Botulinum Toxin Administration to Treat Various Conditions
05/10/2012US20120114702 Compositions and methods for treating asthma and other lung disorders
05/10/2012US20120114675 Foxp3+ natural killer t-cells and the treatment of immune related diseases
05/10/2012US20120114674 Molecular Antigen Array
05/10/2012US20120114667 TARGETED BINDING AGENTS DIRECTED TO a5BETA1 AND USES THEREOF
05/10/2012US20120114663 Methods to treat allergic conditions
05/10/2012US20120114659 Antibodies for Guanylyl Cyclase Receptors
05/10/2012US20120114654 Human antibodies to human tnf-like ligand 1a (tl1a)
05/10/2012US20120114651 Methods for targeting pulmonary diseases with agents that bind a target in pulmonary tissue
05/10/2012US20120114619 Protein with promoting effects for axonal growth of neurons of central nervous system
05/10/2012US20120114599 Opioid and opioid-like compounds and uses thereof
05/10/2012US20120114591 Treatment of chronic ulcerous skin lesions
05/10/2012US20120114588 Ibat inhibitors for treatment of metabolic disorders and related conditions
05/10/2012US20120114577 Peptide Having Activity of Transforming Growth Factor and Production Method Therefor
05/10/2012US20120114574 Compositions for nail and skin treatment
05/10/2012US20120114570 Collagen extraction from aquatic animals
05/10/2012US20120114566 Lipoxin analogs and methods for the treatment of periodontal disease
05/10/2012US20120114558 Aptamer-mediated drug release
05/10/2012US20120114556 Immunotherapy of autoimmune disorders using antibodies which target b-cells
05/10/2012DE102010050570A1 Zusammensetzung und Arzneimittel enthaltend ω-3-Fettsäuren sowie einen Inhibitor des NF-κB-Transkriptionsfaktors Composition and medicines containing ω-3 fatty acids as well as an inhibitor of NF-kB transcription factor
05/10/2012DE102010048800A1 Chinoxalinderivate Quinoxaline derivatives
05/10/2012CA2829117A1 Novel 6-arylamino pyridone carboxamide as mek inhibitors
05/10/2012CA2819997A1 Preventive or therapeutic agent for pain associated with herpes zoster in acute phase
05/10/2012CA2815792A1 Felbinac-containing external patch
05/10/2012CA2815445A1 5 -cyano-4, 6 -diaminopyrimidine or 6 -aminopurine derivatives as pi3k-delta inhibitors
05/10/2012CA2814057A1 A combination composition
05/10/2012CA2812655A1 Indole derivatives
05/09/2012EP2450352A1 Prophylactic or therapeutic agent for cancer
05/09/2012EP2448958A1 Human milk peptides
05/09/2012EP2448943A1 Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents
05/09/2012EP2448938A1 Pyrimidinones as pi3k inhibitors
05/09/2012EP2448931A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
05/09/2012EP2448920A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
05/09/2012EP2448573A1 Medicament for the long term nsaid use
05/09/2012EP2213292B1 Double-stranded oligonucleotides
05/09/2012EP1613588B1 2-propylidene-19-nor-vitamin d compounds
05/09/2012EP1501467B1 Heterocyclo inhibitors of potassium channel function
05/09/2012CN102448960A Derivatives of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-carboxylic acid amides
05/09/2012CN102448937A Aryl Substituted Carboxamide Derivatives As Calcium Or Sodium Channel Blockers
05/09/2012CN102448930A Thiocolchicine derivatives, method of making and methods of use thereof
05/09/2012CN102448496A Medicine composition having iodine and steroid and application to treatment of rhinitis
05/09/2012CN102448488A Vaccine for mycoplasma infection
05/09/2012CN102448455A Use of flavonoids to increase the bioavailability of hesperetin
05/09/2012CN102445513A A (Absorption)-M (Metabolization)-model-based traditional Chinese medicine new drug discovery policy and medicine and combination thereof
05/09/2012CN102443594A Receptor activator of nuclear factor kappa B ligand (RANKL)-HBaAg expression constructing object, yeast, manufacture method as well as application
05/09/2012CN102443528A Wolfberry yam wine and preparation method thereof
05/09/2012CN102443524A Production method of bone-strengthening blood-tonifying wine
05/09/2012CN102443519A Production method for astragalus mongholicus wine
1 ... 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 ... 1272